Profile avatar
ajkd.bsky.social
AJKD, official journal of @kidney.org, is the leading source of information devoted to clinical nephrology research and practice. AJKD.org | AJKDblog.org | Organizer of #NephMadness @nephmadness.bsky.social
246 posts 2,362 followers 580 following
Prolific Poster

OMG #NephMadness starts in just a few days!!

CALL FOR SUBMISSIONS: Have you encountered a tricky case that could be submitted as a Quiz to help others learn? Details on the #AJKDBlog: https://bit.ly/3OjKpdd All Quizzes are freely available: https://bit.ly/3B4vccS

NEW Commentary by Jenny Pan on the #AJKDBlog: https://bit.ly/4b8LRK1 Y SeX and Gender Differences Matter in CKD: Understanding the Impact on Kidney Function Decline

In recognition of #WorldKidneyDay on March 13, the editors present a collection of AJKD articles that highlight kidney disease research across the world: https://bit.ly/3EUhrPN (FREE) @WorldKidneyDay

One Year at AJKD: A Perspective From the 2023- 2024 Editorial Interns (George Vasquez-Rios, Rachel Shulman, Megan Urbanski, Emmanuel A. Adomako, and Michael L. Granda) https://bit.ly/VasquezRios25Pers

Counting down the Top Ten #NephMadness region posts from 2020-2024: 5️⃣ Thrombotic Microangiopathy Region (2023) https://bit.ly/3ERRvV2 Expert: @anuja_java Writer: @viral_nephro @AkbarNouman Exec: @KidneyWars @Maximal_Change Teams: Primary TMA vs Secondary TMA

Counting down the Top Ten #NephMadness region posts from 2020-2024: 6️⃣ Hyperkalemia (2020) https://bit.ly/4bat8ha Expert: Deborah Clegg Writer: @RyannSohaney Exec: @kidney_boy Teams: -Potassium Binders vs Potassium is Good -Exercise Causes vs Exercise Prevents HyperK

In the Literature (@nejm.org) by Clara J. Fischman and Lawrence B. Holzman: Identification of Nephrin Autoantibodies Signals New Chapter for Glomerular Disease https://bit.ly/4i29I0e (FREE)

Editorial by Anneke Kramer, Rianne Boenink, and Vianda S. Stel: Improved Survival in Patients Receiving Hemodialysis Through Changes in Practice Patterns: Does This Apply to Your Country? https://bit.ly/3CHuTFR (FREE)

Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy bit.ly/43q5c7V #OpenAccess @Podesta_Manuel_ @TrilliniMatias #VisualAbstract

CALL FOR SUBMISSIONS: How has #kidneydisease impacted your life? Consider sharing your experience to our "In A Few Words" feature. We welcome submissions from patients/health professionals/family members. Details on the #AJKDBlog: https://bit.ly/3Zmnx1H

NEW Commentary by Jenny Pan on the #AJKDBlog: https://bit.ly/4b8LRK1 (FREE) Y SeX and Gender Differences Matter in CKD: Understanding the Impact on Kidney Function Decline

Counting down the Top Ten #NephMadness region posts from 2020-2024: 7️⃣ Hyponatremia Correction Region (2024) https://bit.ly/3D1LwMC Expert: @christ-crain.bsky.social Writer: Naman Gupta, Alisha Sharma, Graham Gipson Exec: Anna Vinnikova, Timothy Yau

Quiz: Young man with 1 week of fever, headaches, nonproductive cough, 1 day of dyspnea. Within 36 hours, he had 1 episode of hemoptysis and worsening hypoxia requiring mechanical ventilation. https://bit.ly/4ka9Ts3 (FREE)

AJKD invites applications for its Editorial Internship Program, which will provide editorial experience to early career researchers interested in education, teaching, or medical editing/writing. Apply by April 30. Details: https://bit.ly/AJKDInternApp2025

In the Literature by Biruh T. Workeneh, Linda W. Moore, and William E. Mitch: Revisiting Protein Restriction in Early CKD: Did We Get it Wrong? http://bit.ly/AJKD25WorkenehITL (FREE)

Counting down the Top Ten #NephMadness region posts from 2020-2024: 8️⃣ Hemodialysis (2022) https://bit.ly/3D8FPwk Writer: Bourne Auguste Expert: @danthekidneyman.bsky.social Exec: @pascale-khairallah.bsky.social & @kidneyboy.bsky.social

We urge the Administration and Congress to reconsider and roll back these actions immediately so potential cuts can be made in a thoughtful and safer manner. To do otherwise may result in absolute tragedy for the American people.

Implementation of An Advance Care Planning Intervention in Dialysis Clinics https://bit.ly/419g3S1

Introducing the #NephMadness 2025 Blue Ribbon Panel: https://bit.ly/NephMadness25BRP -Roger Rodby @drdeidracrews.bsky.social -Kirk Campbell @ssfarouk.bsky.social @toates.bsky.social -Meredith Atkinson -Linnys Alcántara Quiroga -Clodagh Sweeney -David Rush

Counting down the Top Ten #NephMadness region posts from 2020-2024: 9️⃣ SGLT2i Region (2020) bit.ly/3a0bb4w Expert: Meg Jardine Writer: @bettercallseeth.bsky.social Exec: @kidneyboy.bsky.social Teams: - TG Feedback vs Non-TG Feedback - SGLT2i in Transplant vs SGLT2i Without Diabetes Mellitus

www.ajkd.org/article/S027... Subspecialization Trends Across 10 Years of the ASN Nephrology Fellow Survey @ajkd.bsky.social

NEW Commentary by Jenny Pan on the #AJKDBlog: Y SeX and Gender Differences Matter in CKD: Understanding the Impact on Kidney Function Decline

Machine Perfusion in Deceased Donor Kidney Transplantation: Editorial Summary of a Cochrane Review by @samjtingle.bsky.social and Colin Hugh Wilson https://bit.ly/AJKD25TingleCCS (FREE)

Counting down the Top Ten #NephMadness region posts from 2020-2024: 10. Preeclampsia (2024) https://bit.ly/4gPRSMO Experts: Jessica Tangren & Michelle Hladunewich Writers: Gilda Portalatin & Connor Grantham Execs: @annaburgner.bsky.social & @ssfarouk.bsky.social

🚨Check out our latest paper in AJKD! We highlighted the importance of unbiased and large-scale genetic testing in ADTKD-MUC1. Using VNtyper, we identified de novo cases and ADTKD was not initially suspected in ~40% of positive cases in our cohort. #ADTKD #MUC1 #VNtyper

In this Core Curriculum, @rwbonner.bsky.social and Gerald Hladik describe the etiologies and pathophysiologic disturbances leading to renal tubular acidoses: https://bit.ly/4aSiXOg (FREE) @UNCKidney

Editorial by Houry Puzantian and Raymond R. Townsend: Three Ankle-Brachial Index Ranges and Incident CKD in Diabetes: A Goldilocks Perspective on the “Just Right” Range https://bit.ly/AJKD24PuzantianED (FREE)

In A Few Words essay by Rajiv Agarwal: Humanizing Nephrology: The Power of Social History https://bit.ly/4hIcZSe (FREE)

Differences in Postoperative Disposition by Kidney Disease Severity: A Population-Based Cohort Study https://bit.ly/AJKD25HarrisonOI #OpenAccess #VisualAbstract

Development of a Patient Reported Outcome Measure of Side Effects for Patients Taking Calcineurin Inhibitors: The FACIT-CNI-Ntx https://bit.ly/3WFr2Qi #OpenAccess @gratefull080504.bsky.social #VisualAbstract

AJKD invites applications for its Editorial Internship Program, which will provide editorial experience to early career researchers interested in education, teaching, or medical editing/writing. Apply by April 30. Details: https://bit.ly/AJKDInternApp2025

Check out the most popular articles from the January-December 2024 issues of AJKD: https://bit.ly/AJKDPopularCollection (FREE)

#RenalPath: Diffuse mesangial sclerosis with glomerular sclerosis and interstitial fibrosis (periodic acid–Schiff stain). https://bit.ly/4hxX6hm (FREE)

Chronic Tonsillitis and IgA Nephropathy: Findings From a Nationwide Japanese Cohort Study https://bit.ly/3WOiOWb #OpenAccess #VisualAbstract #IgAN

NEW on the #AJKDBlog: Timothy Yau interviews Anna Gaddy, @amyaimei.bsky.social , and Murugapandian about the rapidly changing landscape of viral nephropathies:

#Quiz from June '24: A 35-yr-old patient with ESKD and FSGS was on CCPD. She developed peritonitis, returned to HD, and then to PD; after her return to PD, she had recurrent episodes of fluid overload. What is the diagnosis? https://bit.ly/3B9AiEQ (FREE)

Association of Coprescribing of Gabapentinoid and Other Psychoactive Medications With Altered Mental Status and Falls in Adults Receiving Dialysis https://bit.ly/4jE4Wb3 #OpenAccess #VisualAbstract

In the Literature (@naturegenet.bsky.social) commentary by Cassianne Robinson-Cohen and Joachim H. Ix: Tubular Epithelial Cells are the Genetic Epicenter for Kidney Function https://bit.ly/40JS22z (FREE)

⚡️AJKD Express is an expedited consideration process for full-length original research articles: Authors of eligible #AJKDExpress articles will be notified of decision within 7-16 business days.⚡️ Details on #AJKDBlog: https://bit.ly/41vn7ZH

Editorial by Jung-Im Shin, Antoine Créon, and Juan-Jesus Carrero: Metformin in People With Diabetes and Advanced CKD: Should We Dare? https://bit.ly/3P4BPzy (FREE)

NEW on the #AJKDBlog: Timothy Yau interviews Anna Gaddy, @amyaimei.bsky.social , and Murugapandian about the rapidly changing landscape of viral nephropathies:

Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials https://bit.ly/42Hkwwh #OpenAccess #VisualAbstract

This month's cover is inspired by #NephMadness 2025! Special thanks to the Executive Team: @nephrosparks.bsky.social, @annaburgner.bsky.social, @kidneywars.bsky.social, Elena Cervantes, @jrkott27.bsky.social, Ana Catalina Alvarez-Elías, Dia Waguespack, and Krithika Mohan.

Renal Arteriovenous Gradients for Greater Than 10,000 Circulating Proteins https://bit.ly/4hoJ0iC (FREE)

Introducing the #NephMadness 2025 Blue Ribbon Panel: https://bit.ly/NephMadness25BRP -Roger Rodby @drdeidracrews.bsky.social -Kirk Campbell @ssfarouk.bsky.social @toates.bsky.social -Meredith Atkinson -Linnys Alcántara Quiroga -Clodagh Sweeney -David Rush

Check out the most popular articles from the January-December 2024 issues of AJKD: https://bit.ly/AJKDPopularCollection (FREE)

New Commentary by Becky Mingyao Ma on the #AJKDBlog: Uncovering the Unknowns in Nephrology https://bit.ly/40DFGbW (FREE) Article by Blasco et al: https://bit.ly/4faYO6u